The Emory Neuromodulation and Technology Innovation Center (ENTICe) has received a $100,000 gift from Axiom Bank to support the development of new treatments for brain diseases and conditions like epilepsy, Parkinson's, depression and more.

ENTICe is a collaborative center that brings together physicians, scientists and biomedical engineers from Emory University and Georgia Tech to facilitate research and technical investigation to solve hurdles and develop new ideas to improve patient outcomes.

Robert E. Gross

"A major focus of our work at ENTICe has been developing novel therapies for patients with drug resistant epilepsy," says Robert E. Gross, MD, PhD, director and co-founder of ENTICe and professor of neurosurgery, neurology, biomedical engineering and neuroscience at Emory University School of Medicine.

Recent research by ENTICe has led to patient-specific therapies through a computational framework that allows for better predictability of a seizure and ultimately will help a neurostimulation device deliver the appropriate stimulation as early as possible to prevent seizure.

"This gift will allow us to continue to refine more effective ways to deliver the correct dose of stimulation at the right time and the right location in the brain and relieve suffering for patients," says Gross.

Axiom Bank, a community bank headquartered in Central Florida, made the gift as part of its continued commitment to supporting community and addressing the needs of people, even beyond its home state.

"Axiom Bank is very proud to give back to the communities we serve," says Angelo Palombi, CEO. "We hope that our donation to ENTICe enables the Emory School of Medicine to continue to expand its program and develop new and exciting treatments for neurological diseases."

Axiom Bank is a Member FDIC and an Equal Housing Lender.